Trademark applications and grants for Myeloid Therapeutics, Inc.. Myeloid Therapeutics, Inc. has 2 trademark applications. The latest application filed is for "ATAK"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | c/o Newpath Partners LP 800 Boylston St., Ste 2222 Boston, MASSACHUSETTS UNITED STATES 02199 |
Patent Application | Date |
---|---|
CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER 20220249552 - 17/715558 Wagner; Samuel C. ;   et al. | 2022-08-11 |
MACROPHAGE SPECIFIC ENGAGER COMPOSITIONS AND METHODS OF USE THEREOF 20220241428 - 17/618349 GETTS; Daniel ;   et al. | 2022-08-04 |
CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER 20220233586 - 17/715710 Wagner; Samuel C. ;   et al. | 2022-07-28 |
CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER 20220202856 - 17/672415 WAGNER; Samuel C. ;   et al. | 2022-06-30 |
METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION 20220184230 - 17/687395 Getts; Daniel ;   et al. | 2022-06-16 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "ATAK" 88450728 |
ATAK 2019-05-29 |
![]() "ATAK MACROPHAGE" 88450714 |
ATAK MACROPHAGE 2019-05-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.